Answers are grounded in this paper and cite their sources.
The plasma-modified clinoptilolite (PMC) nanorods were prepared from natural clinoptilolite (NC) utilizing environmentally-friendly corona discharge plasma. The PMC and NC were characterized by XRD, FT-IR, SEM, EDX, XPS and BET, which confirmed the nanocatalyst formation. The catalytic performance of the PMC in the heterogeneous sono-Fenton-like process was greater than the NC for treatment of phenazopyridine (PhP). The desired amounts were obtained for experimental parameters including initial pH (5), PMC dosage (2g/L), K2S2O8 concentration (2mmol/L), ultrasonic power (300W) and PhP concentration (10mg/L). Reactive oxygen species scavengers decreased the removal efficiency of the PhP. The treatment process followed pseudo-first order kinetic and seven degradation intermediates were identified by the GC-MS technique.
No takes yet. Share an insight, caveat, or question.
Khataee et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: